PMID- 19457299 OWN - NLM STAT- MEDLINE DCOM- 20090811 LR - 20191210 IS - 1555-2101 (Electronic) IS - 0160-6689 (Linking) VI - 70 IP - 7 DP - 2009 Jul TI - The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms. PG - 952-7 LID - 10.4088/JCP.08m04728 [doi] AB - OBJECTIVE: A recently proposed multidimensional method of staging treatment resistance in depression, the Maudsley Staging Method (MSM), has been shown to predict short-term outcome of treatment. This study tested whether the MSM predicts longer-term clinical outcome. We hypothesized that patients with higher scores on the MSM would experience a worse longer-term outcome in terms of time spent in a depressive episode and level of functional impairment. METHOD: From May through July of 2008, we followed up patients with treatment-resistant depression discharged from an inpatient unit of an affective disorders service; all had MSM scores previously calculated from preadmission clinical data. We used the Longitudinal Interval Follow-up Evaluation (LIFE) chart to determine the monthly symptomatic course of depression blind to initial MSM scores. We employed a regression model to adjust for various confounding factors, including variable duration of follow-up, to determine the independent association of MSM scores with persistence of depressive disorder. RESULTS: We assessed 62 of 80 eligible patients (78%) in a median follow-up duration (interquartile range) of 29.5 (19.0-52.5) months. The MSM independently predicted (1) being in an episode for 50% or longer of the follow-up duration (OR = 2.11, 95% CI = 1.25 to 3.57), (2) being in an episode at the time of follow-up assessment (OR = 1.89, 95% CI = 1.17 to 3.05), (3) being persistently in an episode throughout the follow-up period (OR = 2.01, 95% CI = 1.14 to 3.54), and (4) total months spent in a depressive episode (OR = 1.22, 95% CI = 1.06 to 1.40). The MSM also predicted functional impairment. Antidepressant count and the Thase and Rush model did not independently predict persistence of depression or functional impairment. CONCLUSION: The MSM appears to have reasonable predictive validity regarding the longer-term course of illness, particularly persistence of depressive episodes. The MSM may be a useful, and possibly an improved, alternative to existing models of staging of treatment-resistant depression. CI - (c)Copyright 2009 Physicians Postgraduate Press, Inc. FAU - Fekadu, Abebaw AU - Fekadu A AD - Institute of Psychiatry, Section of Neurobiology of Mood Disorders, Department of Psychological Medicine and Psychiatry, King's College London, United Kingdom. FAU - Wooderson, Sarah C AU - Wooderson SC FAU - Markopoulou, Kalypso AU - Markopoulou K FAU - Cleare, Anthony J AU - Cleare AJ LA - eng PT - Comparative Study PT - Journal Article DEP - 20090519 PL - United States TA - J Clin Psychiatry JT - The Journal of clinical psychiatry JID - 7801243 RN - 0 (Antidepressive Agents) SB - IM MH - Antidepressive Agents/*therapeutic use MH - Depression/diagnosis/psychology MH - Depressive Disorder/*diagnosis/drug therapy MH - Depressive Disorder, Major/diagnosis/drug therapy MH - Disability Evaluation MH - Drug Resistance MH - Female MH - Follow-Up Studies MH - Humans MH - Logistic Models MH - Longitudinal Studies MH - Male MH - Middle Aged MH - Outcome Assessment, Health Care/*methods/statistics & numerical data MH - Prognosis MH - Psychiatric Status Rating Scales MH - Psychometrics MH - Severity of Illness Index EDAT- 2009/05/22 09:00 MHDA- 2009/08/12 09:00 CRDT- 2009/05/22 09:00 PHST- 2008/09/20 00:00 [received] PHST- 2009/01/02 00:00 [accepted] PHST- 2009/05/22 09:00 [entrez] PHST- 2009/05/22 09:00 [pubmed] PHST- 2009/08/12 09:00 [medline] AID - 10.4088/JCP.08m04728 [doi] PST - ppublish SO - J Clin Psychiatry. 2009 Jul;70(7):952-7. doi: 10.4088/JCP.08m04728. Epub 2009 May 19.